Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039080 | SCV000062758 | likely benign | not specified | 2012-04-11 | criteria provided, single submitter | clinical testing | Ala117Ala in exon 3 of JUP: This variant is not expected to have clinical signif icance because it does not alter an amino acid residue and it is not located wit hin the splice consensus sequence. Ala117Ala in exon 3 of JUP (allele frequenc y = n/a) |
Labcorp Genetics |
RCV001454132 | SCV001657844 | likely benign | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2024-10-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001534116 | SCV001751014 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002453320 | SCV002613241 | likely benign | Cardiovascular phenotype | 2019-08-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |